Meeting Overview

View Topics and Working Groups

Thursday 17 Oct Friday 18 Oct Saturday 19 Oct Sunday 20 Oct
Morning Y-EHTG plenary session Parallel Working Groups on:
Gastroenterology, Surgery, Immunology and Pathology, Gene Panel Testing and Counselling, Gynecology, Urology, Dermatology, Microbiome and Environmental Factors, Chemoprevention, Guidance for LS, Guidance for Polyposis Syndromes, Patient Representatives
EHTG Membership Meeting Patients Session

Collaborative Studies

Specific Working Groups:

  • Registries
  • Surgery
  • ASS & Chemoprevention
Abstract Presentations Abstract Presentations
Lunchtime Lunch in the Poster and Exhibition Area
Afternoon Symposium State of the Art Lectures:

  • Over-diagnosis
  • Over-treatment

 

Parallel Working Groups on:
Gastroenterology, Surgery, Immunology and Pathology, Gene Panel Testing and Counselling, Gynecology, Urology, Dermatology, Microbiome and Environmental Factors, Chemoprevention, Guidance for LS, Guidance for Polyposis Syndromes, Patient Representatives
Symposium
State of the Art Lectures:

  • Chemoprevention
  • Polyposis syndromes
  • Lynch syndrome
  • Hot topics

 

Abstract Presentations
Evening Welcome Reception
for all delegates and sponsors in the Poster & Exhibition Area Time to be confirmed
Farewell Drinks Reception
for all delegates and sponsors in the Poster & Exhibition Area

Topics include:

  • Gene specific considerations in Lynch Syndrome
  • Genetic testing – when, what, why
  • New genes and syndromes
  • Polyposis Syndromes
  • Debate: management of upper GI neoplasia in FAP
  • Desmoid tumours
  • (Sub) total coletomy: ileorectal versus ileosigmoid anastomosis
  • Update on ASS
  • Genetic studies in minorities populations
  • Guidance Updates
  • Cost – efficacy considerations
  • PD1 inhibitors for unstable tumours

Working Groups on:

  • Gastroenterology
  • Surgery
  • Immunology and pathology
  • Gene panel testing and counselling
  • Gynecology
  • Urology
  • Dermatology
  • Microbiome and environmental factors – chemoprevention
  • Guidance for LS
  • Guidance for polyposis syndromes
  • Patient representatives
Top